| 1 |
31056264 | A novel mechanism of irinotecan targeting MDM2 and Bcl-xL. | 2019 Jun 25 |
6 |
| 2 |
24173769 | Berberine enhances chemosensitivity to irinotecan in colon cancer via inhibition of NF‑κB. | 2014 Jan |
1 |
| 3 |
20619636 | Aven blocks DNA damage-induced apoptosis by stabilising Bcl-xL. | 2010 Sep |
1 |
| 4 |
18609706 | Bcl-x(L) and Myeloid cell leukaemia-1 contribute to apoptosis resistance of colorectal cancer cells. | 2008 Jun 28 |
1 |
| 5 |
17273826 | Short hairpin RNAs targeting Bcl-xL modulate senescence and apoptosis following SN-38 and irinotecan exposure in a colon cancer model. | 2007 Oct |
4 |
| 6 |
17609585 | Irinotecan activates p53 with its active metabolite, resulting in human hepatocellular carcinoma apoptosis. | 2007 Jul |
1 |
| 7 |
17666793 | Irinotecan-induced apoptosis is inhibited by increased P-glycoprotein expression and decreased p53 in human hepatocellular carcinoma cells. | 2007 Aug |
2 |
| 8 |
15604280 | Elimination of hepatic metastases of colon cancer cells via p53-independent cross-talk between irinotecan and Apo2 ligand/TRAIL. | 2004 Dec 15 |
1 |
| 9 |
12855666 | Antisense Bcl-xl down-regulation switches the response to topoisomerase I inhibition from senescence to apoptosis in colorectal cancer cells, enhancing global cytotoxicity. | 2003 Jul |
2 |